Tag: Acrylamides

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Acrylamides

New Data Demonstrate Long-Term Benefit of IMBRUVICA® (ibrutinib) as First-Line Treatment for ...

Added to Collection on: 2020-12-06 18:00:00

Tags for this article:

Orphan drugs
Drugs
Clinical medicine
Health sciences
Tyrosine kinase inhibitors
Breakthrough therapy
Acrylamides
Ibrutinib
Pyrazolopyrimidines
Chronic lymphocytic leukemia
Mantle cell lymphoma
Bruton's tyrosine kinase
Janssen Pharmaceutical Companies
United States

Click the tags to see associated articles and topics

View Article Details
TG Therapeutics Announces Publication of Final Results from the Phase 3 GENUINE Trial ...

Added to Collection on: 2021-02-23 12:22:30

Tags for this article:

Drugs
Orphan drugs
Health sciences
Health care
Breakthrough therapy
Tyrosine kinase inhibitors
Acrylamides
Ibrutinib
Pyrazolopyrimidines
Chronic lymphocytic leukemia
Rituximab
Bruton's tyrosine kinase
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Ianalumab/Ibrutinib Combo Shows Promising Activity in CLL

Added to Collection on: 2021-02-26 18:33:45

Tags for this article:

Orphan drugs
Chemical compounds
Breakthrough therapy
Tyrosine kinase inhibitors
Drugs
Organic compounds
Acrylamides
Ibrutinib
Pyrazolopyrimidines
Chronic lymphocytic leukemia
Leukemia
CLL

Click the tags to see associated articles and topics

View Article Details
Imbruvica Plus Novel Agent May Improve Progression-Free Survival in Chronic Lymphocytic ...

Added to Collection on: 2021-03-03 19:02:29

Tags for this article:

Chemical compounds
Orphan drugs
Organic compounds
Tyrosine kinase inhibitors
Drugs
Acrylamides
Breakthrough therapy
Ibrutinib
Pyrazolopyrimidines
Chronic lymphocytic leukemia
Bruton's tyrosine kinase
Jeff Sharman
TG-1101

Click the tags to see associated articles and topics

View Article Details
Ublituximab Added to Ibrutinib Demonstrates ORR Benefit for Relapsed/Refractory CLL

Added to Collection on: 2021-03-09 23:03:45

Tags for this article:

Orphan drugs
Drugs
Health sciences
Health care
Breakthrough therapy
Tyrosine kinase inhibitors
Acrylamides
Ibrutinib
Pyrazolopyrimidines
Chronic lymphocytic leukemia
Bruton's tyrosine kinase
Rituximab
TGTX-1101
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
AbbVie (ABBV) Signs New Cancer/Immunology Deal With Frontier - Yahoo Life UK

Added to Collection on: 2024-06-02 22:40:48

Tags for this article:

Orphan drugs
Acrylamides
Ibrutinib
Piperidines
Pyrazolopyrimidines
Boehringer Ingelheim
ABBVIE’S
Frontier Medicines, Corp.

Click the tags to see associated articles and topics

View Article Details
Adding a Kinase to Pembrolizumab May Increase CLL Treatment Efficacy

Added to Collection on: 2024-07-16 21:03:03

Tags for this article:

Antineoplastic drugs
Orphan drugs
Acrylamides
Piperidines
Chronic lymphocytic leukemia
Ibrutinib
Pembrolizumab
Idelalisib
Richter's transformation

Click the tags to see associated articles and topics

View Article Details
Neoadjuvant Osimertinib With or Without Chemotherapy Improves Response in Resectable ...

Added to Collection on: 2025-06-04 19:09:04

Tags for this article:

Lung cancer
Orphan drugs
Acrylamides
Ethers
Osimertinib
Pyrimidines
Non-small-cell lung cancer
Adjuvant therapy
Epidermal growth factor receptor
Durvalumab

Click the tags to see associated articles and topics

View Article Details
July FDA Oncology Approvals Include Options for NSCLC, Myeloma, and More

Added to Collection on: 2025-08-01 14:08:03

Tags for this article:

Orphan drugs
Tyrosine kinase inhibitors
Acrylamides
Piperidines
SIR-Spheres
Selective internal radiation therapy
Sirtex
Ibrutinib
Sunvozertinib
Waldenström macroglobulinemia
Epidermal growth factor receptor
Pembrolizumab

Click the tags to see associated articles and topics

View Article Details
Arrivent BioPharma, Inc. Presents the Final Analysis of Firmonertinib Monotherapy Data from ...

Added to Collection on: 2025-09-09 17:10:19

Tags for this article:

Antineoplastic drugs
Lung cancer
Acrylamides
Oncogenes
Tyrosine kinase receptors
Non-small-cell lung cancer
HER2
Epidermal growth factor receptor
Gefitinib
Zipalertinib
ArriVent Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo